Drugs List

Drugs A-Z List - O
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Drugs List [Browse by brand or generic name]
Obizur Antihemophilic Factor (Recombinant), Porcine Seque - FDA

Description : The active ingredient in OBIZUR is a recombinant (r) analogue of porcine factor VIII (pFVIII) w...

  • Indications
  • OBIZUR, Antihemophilic Factor (Recombinant), Porcine Sequence, is a recombinant DNA derived, antihemophilic factor indicated for the treatment of bleeding episodes in adul
  •   Read More
Obizur Antihemophilic Factor (Recombinant), Porcine Seque - FDA

Description : The active ingredient in OBIZUR is a recombinant (r) analogue of porcine factor VIII (pFVII...

  • Indications
  • OBIZUR, Antihemophilic Factor (Recombinant), Porcine Sequence, is a recombinant DNA derived, antihemophilic factor indicated for the treatment of bleeding episodes in adul
  •   Read More
Obredon hydrocodone bitartrate and guaifenesin) Oral Solut - FDA

Description : OBREDON Oral Solution contains hydrocodone bitartrate (a centrally-acting opioid antitussiv...

  • Indications
  • OBREDON Oral Solution is indicated for symptomatic relief of cough and to loosen mucus associated with the common cold. Important Limitations of Use Not indicated for pe
  •   Read More
Obredon  (hydrocodone bitartrate and guaifenesin) Oral Sol - FDA

Description : OBREDON Oral Solution contains hydrocodone bitartrate (a centrally-acting opioid antitussiv...

  • Indications
  • OBREDON Oral Solution is indicated for symptomatic relief of cough and to loosen mucus associated with the common cold. Important Limitations of Use Not indicated for pediat
  •   Read More
Ocucoat (hydroxypropylmethylcellulose) - FDA

Description : OCUCOAT (hydroxypropylmethylcellulose) is a sterile, isotonic, nonpyrogenic viscoelastic so...

  • Indications
  • OCUCOAT (hydroxypropylmethylcellulose) is indicated for use as an ophthalmic surgical aid in anterior segment surgical procedures, including cataract extraction and intraocula
  •   Read More
Ocucoat hydroxypropylmethylcellulose - FDA

Description : OCUCOAT (hydroxypropylmethylcellulose) is a sterile, isotonic, nonpyrogenic viscoelastic so...

  • Indications
  • OCUCOAT (hydroxypropylmethylcellulose) is indicated for use as an ophthalmic surgical aid in anterior segment surgical procedures, including cataract extraction and intrao
  •   Read More
Ocufen flurbiprofen ophthalmic (Pronunciation: FLUR bi PR - FDA

Description : OCUFEN® (flurbiprofen sodium ophthalmic solution, USP) 0.03% is a sterile topical nonst...

  • Indications
  • OCUFEN® ophthalmic solution is indicated for the inhibition of intraoperative miosis.
  •   Read More
Ocufen flurbiprofen ophthalmic (Pronunciation: FLUR bi PR - Multum

Description : OCUFEN® (flurbiprofen sodium ophthalmic solution, USP) 0.03% is a sterile topical nonst...

  • Indications
  • OCUFEN® ophthalmic solution is indicated for the inhibition of intraoperative miosis.
  •   Read More
Ocufen flurbiprofen ophthalmic (Pronunciation: FLUR bi PR - FDA

Description : OCUFEN® (flurbiprofen sodium ophthalmic solution, USP) 0.03% is a sterile topical nonst...

  • Indications
  • OCUFEN® ophthalmic solution is indicated for the inhibition of intraoperative miosis.
  •   Read More
Ocuflox ofloxacin ophthalmic (Pronunciation: oh FLOX a sin - FDA

Description : OCUFLOX (ofloxacin ophthalmic solution) 0.3% is a sterile ophthalmic solution. It is a fluo...

  • Indications
  • OCUFLOX (ofloxacin ophthalmic) ® ophthalmic solution is indicated for the treatment of infections caused by susceptible strains of the following bacteria in the conditions
  •   Read More
Ocuflox ofloxacin ophthalmic (Pronunciation: oh FLOX a sin - Multum

Description : OCUFLOX (ofloxacin ophthalmic solution) 0.3% is a sterile ophthalmic solution. It is a fluo...

  • Indications
  • OCUFLOX (ofloxacin ophthalmic) ® ophthalmic solution is indicated for the treatment of infections caused by susceptible strains of the following bacteria in the conditions
  •   Read More
Ocuflox ofloxacin ophthalmic (Pronunciation: oh FLOX a sin - FDA

Description : OCUFLOX (ofloxacin ophthalmic solution) 0.3% is a sterile ophthalmic solution. It is a fluo...

  • Indications
  • OCUFLOX (ofloxacin ophthalmic) ® ophthalmic solution is indicated for the treatment of infections caused by susceptible strains of the following bacteria in the conditions
  •   Read More
Ocuflox ofloxacin ophthalmic (Pronunciation: oh FLOX a sin - Multum

Description : OCUFLOX (ofloxacin ophthalmic solution) 0.3% is a sterile ophthalmic solution. It is a fluo...

  • Indications
  • OCUFLOX (ofloxacin ophthalmic) ® ophthalmic solution is indicated for the treatment of infections caused by susceptible strains of the following bacteria in the conditions
  •   Read More
Ocupress carteolol ophthalmic (Pronunciation: kar TEE oh lo - FDA

Description : Carteolol Hydrochloride (carteolol) Ophthalmic Solution USP, 1% is a nonselective beta-adre...

  • Indications
  • Carteolol Hydrochloride (carteolol) Ophthalmic Solution 1% has been shown to be effective in lowering intraocular pressure and may be used in patients with chronic open-an
  •   Read More
Ocupress carteolol ophthalmic (Pronunciation: kar TEE oh lo - Multum

Description : Carteolol Hydrochloride (carteolol) Ophthalmic Solution USP, 1% is a nonselective beta-adre...

  • Indications
  • Carteolol Hydrochloride (carteolol) Ophthalmic Solution 1% has been shown to be effective in lowering intraocular pressure and may be used in patients with chronic open-an
  •   Read More
Ocupress carteolol ophthalmic (Pronunciation: kar TEE oh lo - FDA

Description : Carteolol Hydrochloride (carteolol) Ophthalmic Solution USP, 1% is a nonselective beta-adre...

  • Indications
  • Carteolol Hydrochloride (carteolol) Ophthalmic Solution 1% has been shown to be effective in lowering intraocular pressure and may be used in patients with chronic open-an
  •   Read More
Ocupress carteolol ophthalmic (Pronunciation: kar TEE oh lo - Multum

Description : Carteolol Hydrochloride (carteolol) Ophthalmic Solution USP, 1% is a nonselective beta-adre...

  • Indications
  • Carteolol Hydrochloride (carteolol) Ophthalmic Solution 1% has been shown to be effective in lowering intraocular pressure and may be used in patients with chronic open-angle
  •   Read More
Ofev (nintedanib) Capsules - FDA

Description : OFEV capsules contain nintedanib, a kinase inhibitor [see Mechanism of Action]. Nintedanib ...

  • Indications
  • OFEV is indicated for the treatment of idiopathic pulmonary fibrosis (IPF).
  •   Read More
Ofev (nintedanib) Capsules - FDA

Description : OFEV capsules contain nintedanib, a kinase inhibitor [see Mechanism of Action]. Nintedanib ...

  • Indications
  • OFEV is indicated for the treatment of idiopathic pulmonary fibrosis (IPF).
  •   Read More
OFIRMEV  (acetaminophen) Injection - FDA

Description : Acetaminophen is a non-salicylate antipyretic and non-opioid analgesic agent. Its chemical ...

  • Indications
  • OFIRMEV® (acetaminophen) injection is indicated for the management of mild to moderate pain the management of moderate to severe pain with adjunctive opioid analge
  •   Read More
Ofirmev acetaminophen (injection) (Pronunciation: a SEET a - FDA

Description : Acetaminophen is a non-salicylate antipyretic and non-opioid analgesic agent. Its chemical ...

  • Indications
  • OFIRMEV® (acetaminophen) injection is indicated for the management of mild to moderate pain the management of moderate to severe pain with adjunctive opioid analge
  •   Read More
Ofirmev acetaminophen (injection) (Pronunciation: a SEET a - Multum

Description : Acetaminophen is a non-salicylate antipyretic and non-opioid analgesic agent. Its chemical ...

  • Indications
  • OFIRMEV® (acetaminophen) injection is indicated for the management of mild to moderate pain the management of moderate to severe pain with adjunctive opioid analge
  •   Read More
Ofloxacin Ophthalmic Solution OFLOXACIN OPHTHALMIC SOLUTION USP, 0.3% - FDA

Description : Ofloxacin Ophthalmic Solution USP, 0.3% is a sterile ophthalmic solution. It is a fluorinat...

  • Indications
  • Ofloxacin ophthalmic solution is indicated for the treatment of infections caused by susceptible strains of the following bacteria in the conditions listed below: CONJU
  •   Read More
Oforta fludarabine (oral) (Pronunciation: floo DAR a been - FDA

Description : The chemical name for fludarabine phosphate is 9H-Purin-6-amine, 2-fluoro-9-(5-O-phosphono-...

  • Indications
  • Oforta™ (fludarabine phosphate tablets) for oral use is indicated as a single agent for the treatment of adult patients with B-cell chronic lymphocytic leukemia (CLL
  •   Read More
Oforta fludarabine (oral) (Pronunciation: floo DAR a been - Multum

Description : The chemical name for fludarabine phosphate is 9H-Purin-6-amine, 2-fluoro-9-(5-O-phosphono-...

  • Indications
  • Oforta™ (fludarabine phosphate tablets) for oral use is indicated as a single agent for the treatment of adult patients with B-cell chronic lymphocytic leukemia (CLL
  •   Read More
Oforta  fludarabine (oral) (Pronunciation: floo DAR a been - FDA

Description : The chemical name for fludarabine phosphate is 9H-Purin-6-amine, 2-fluoro-9-(5-O-phosphono-...

  • Indications
  • Oforta™ (fludarabine phosphate tablets) for oral use is indicated as a single agent for the treatment of adult patients with B-cell chronic lymphocytic leukemia (CLL) wh
  •   Read More
Oforta  fludarabine (oral) (Pronunciation: floo DAR a bee - Multum

Description : The chemical name for fludarabine phosphate is 9H-Purin-6-amine, 2-fluoro-9-(5-O-phosphono-...

  • Indications
  • Oforta™ (fludarabine phosphate tablets) for oral use is indicated as a single agent for the treatment of adult patients with B-cell chronic lymphocytic leukemia (CLL) wh
  •   Read More
Ogen 0.625, Ogen 1.25, Ogen 2.5 estropipate (Pronunciation: ES troe PIP ate) - FDA

Description : OGEN (estropipate tablets), (formerly piperazine estrone sulfate), is a natural estrogen (estro...

  • Indications
  • OGEN (estropipate) is indicated in the: Treatment of moderate to severe vasomotor symptoms associated with themenopause. Treatment of moderate to severe symptoms
  •   Read More
Ogen 0.625, Ogen 1.25, Ogen 2.5 estropipate (Pronunciation: ES troe PIP ate) - Multum

Description : OGEN (estropipate tablets), (formerly piperazine estrone sulfate), is a natural estrogen ...

  • Indications
  • OGEN (estropipate) is indicated in the: Treatment of moderate to severe vasomotor symptoms associated with themenopause. Treatment of moderate to severe symptoms
  •   Read More
Ogen 0.625, Ogen 1.25, Ogen 2.5 estropipate (Pronunciation: ES troe PIP ate) - FDA

Description : OGEN (estropipate tablets), (formerly piperazine estrone sulfate), is a natural estrogen (e...

  • Indications
  • OGEN (estropipate) is indicated in the: Treatment of moderate to severe vasomotor symptoms associated with the menopause. Treatment of moderate to severe symptoms of v
  •   Read More
Ogen 0.625, Ogen 1.25, Ogen 2.5 estropipate (Pronunciation: ES troe PIP ate) - Multum

Description : OGEN (estropipate tablets), (formerly piperazine estrone sulfate), is a natural estrogen (e...

  • Indications
  • OGEN (estropipate) is indicated in the: Treatment of moderate to severe vasomotor symptoms associated with the menopause. Treatment of moderate to severe symptoms of v
  •   Read More
Olysio  OLYSIO┬« is a hepatitis C virus (HCV) NS3/4A pro - FDA

Description : OLYSIO (simeprevir) is an inhibitor of the HCV NS3/4A protease. The chemical name for sim...

  • Indications
  • OLYSIO® is a hepatitis C virus (HCV) NS3/4A protease inhibitor indicated for the treatment of chronic hepatitis C (CHC) genotype 1 infection as a component of a combi
  •   Read More
Olysio (simeprevir) Capsules - FDA

Description : OLYSIO (simeprevir) is an inhibitor of the HCV NS3/4A protease. The chemical name for simepre...

  • Indications
  • OLYSIO® is a hepatitis C virus (HCV) NS3/4A protease inhibitor indicated for the treatment of chronic hepatitis C (CHC) genotype 1 infection as a component of a combi
  •   Read More
Omidria (phenylephrine and ketorolac) Injection - FDA

Description : Omidria is a sterile aqueous solution concentrate containing the α1-adrenergic recept...

  • Indications
  • Omidria™ is added to an ophthalmic irrigation solution used during cataract surgery or intraocular lens replacement and is indicated for maintaining pupil size by
  •   Read More
Omidria phenylephrine and ketorolac) Injection - FDA

Description : Omidria is a sterile aqueous solution concentrate containing the α1-adrenergic recept...

  • Indications
  • Omidria™ is added to an ophthalmic irrigation solution used during cataract surgery or intraocular lens replacement and is indicated for maintaining pupil size by prev
  •   Read More
Omnaris ciclesonide nasal (Pronunciation: sik le SON ide) - FDA

Description : The active component of OMNARIS Nasal Spray is ciclesonide, a non-halogenated glucocorticoi...

  • Indications
  • Treatment of Seasonal Allergic Rhinitis OMNARIS Nasal Spray is indicated for the treatment of nasal symptoms associated with seasonal allergic rhinitis in adults and chil
  •   Read More
Omnaris ciclesonide nasal (Pronunciation: sik le SON ide) - Multum

Description : The active component of OMNARIS Nasal Spray is ciclesonide, a non-halogenated glucocorticoi...

  • Indications
  • Treatment of Seasonal Allergic Rhinitis OMNARIS Nasal Spray is indicated for the treatment of nasal symptoms associated with seasonal allergic rhinitis in adults and chil
  •   Read More
Omnaris ciclesonide nasal (Pronunciation: sik le SON ide - FDA

Description : The active component of OMNARIS Nasal Spray is ciclesonide, a non-halogenated glucocorticoi...

  • Indications
  • Treatment of Seasonal Allergic Rhinitis OMNARIS Nasal Spray is indicated for the treatment of nasal symptoms associated with seasonal allergic rhinitis in adults and chil
  •   Read More
Omnaris ciclesonide nasal (Pronunciation: sik le SON ide) - Multum

Description : The active component of OMNARIS Nasal Spray is ciclesonide, a non-halogenated glucocorticoi...

  • Indications
  • Treatment of Seasonal Allergic Rhinitis OMNARIS Nasal Spray is indicated for the treatment of nasal symptoms associated with seasonal allergic rhinitis in adults and chil
  •   Read More
Omnicef, Omnicef Omni-Pac cefdinir (Pronunciation: SEF dih neer) - FDA

Description :   Proprietary name: OMNICEF Established name: cefdinir Route of administration: O...

  • Indications
  • To reduce the development of drug-resistant bacteria and maintain the effectiveness of OMNICEF (cefdinir) and other antibacterial drugs, OMNICEF (cefdinir) should be used
  •   Read More
Omnicef, Omnicef Omni-Pac cefdinir (Pronunciation: SEF dih neer) - Multum

Description :   Proprietary name: OMNICEF Established name: cefdinir Route of administration: O...

  • Indications
  • To reduce the development of drug-resistant bacteria and maintain the effectiveness of OMNICEF (cefdinir) and other antibacterial drugs, OMNICEF (cefdinir) should be used
  •   Read More
Omnicef, Omnicef Omni-Pac cefdinir (Pronunciation: SEF dih neer) - Multum

Description :   Proprietary name: OMNICEF Established name: cefdinir Route of administration: O...

  • Indications
  • To reduce the development of drug-resistant bacteria and maintain the effectiveness of OMNICEF (cefdinir) and other antibacterial drugs, OMNICEF (cefdinir) should be used
  •   Read More
Omniscan gadodiamide) Injection for Intravenous - FDA

Description : OMNISCAN (gadodiamide) Injection is the formulation of the gadolinium complex of diethylene...

  • Indications
  • CNS (Central Nervous System) OMNISCAN is a gadolinium-based contrast agent indicated for intravenous use in MRI to visualize lesions with abnormal vascularity (or those
  •   Read More
Omniscan gadodiamide) Injection for Intravenous Use - FDA

Description : OMNISCAN (gadodiamide) Injection is the formulation of the gadolinium complex of diethylene...

  • Indications
  • CNS (Central Nervous System) OMNISCAN is a gadolinium-based contrast agent indicated for intravenous use in MRI to visualize lesions with abnormal vascularity (or those
  •   Read More
Omontys peginesatide (Pronunciation: PEG in ES a tide) - FDA

Description : Peginesatide is an ESA that is a synthetic, pegylated dimeric peptide comprised of two iden...

  • Indications
  • Anemia Due to Chronic Kidney Disease OMONTYS® is indicated for the treatment of anemia due to chronic kidney disease (CKD) in adult patients on dialysis. Limitation
  •   Read More
Omontys peginesatide (Pronunciation: PEG in ES a tide - Multum

Description : Peginesatide is an ESA that is a synthetic, pegylated dimeric peptide comprised of two iden...

  • Indications
  • Anemia Due to Chronic Kidney Disease OMONTYS® is indicated for the treatment of anemia due to chronic kidney disease (CKD) in adult patients on dialysis. Limitation
  •   Read More
Omontys peginesatide (Pronunciation: PEG in ES a tide - FDA

Description : Peginesatide is an ESA that is a synthetic, pegylated dimeric peptide comprised of two iden...

  • Indications
  • Anemia Due to Chronic Kidney Disease OMONTYS® is indicated for the treatment of anemia due to chronic kidney disease (CKD) in adult patients on dialysis. Limitation
  •   Read More
Omontys  peginesatide (Pronunciation: PEG in ES a tide) - Multum

Description : Peginesatide is an ESA that is a synthetic, pegylated dimeric peptide comprised of two iden...

  • Indications
  • Anemia Due to Chronic Kidney Disease OMONTYS® is indicated for the treatment of anemia due to chronic kidney disease (CKD) in adult patients on dialysis. Limitation
  •   Read More
Omtryg omega-3-acid ethyl esters A) Capsules - FDA

Description : OMTRYG, a lipid-regulating agent, is supplied as a liquid-filled gel capsule for oral admin...

  • Indications
  • OMTRYG™ (omega-3-acid ethyl esters A) is indicated as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe ( ≥ 500 mg/dL) hypertrig
  •   Read More
Omtryg omega-3-acid ethyl esters A) Capsules - FDA

Description : OMTRYG, a lipid-regulating agent, is supplied as a liquid-filled gel capsule for oral admin...

  • Indications
  • OMTRYG™ (omega-3-acid ethyl esters A) is indicated as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe ( ≥ 500 mg/dL) hypertrig
  •   Read More
Oncaspar pegaspargase (Pronunciation: peg ah SPAR jase) - FDA

Description : Oncaspar® (pegaspargase) is L-asparaginase (L-asparagine amidohydrolase) that is covale...

  • Indications
  • First Line Acute Lymphoblastic Leukemia (ALL) Oncaspar® is indicated as a component of a multi-agent chemotherapeutic regimen for the first line treatment of patients
  •   Read More
Oncaspar pegaspargase (Pronunciation: peg ah SPAR jase - Multum

Description : Oncaspar® (pegaspargase) is L-asparaginase (L-asparagine amidohydrolase) that is covale...

  • Indications
  • First Line Acute Lymphoblastic Leukemia (ALL) Oncaspar® is indicated as a component of a multi-agent chemotherapeutic regimen for the first line treatment of patients
  •   Read More
Oncaspar pegaspargase (Pronunciation: peg ah SPAR jase - FDA

Description : Oncaspar® (pegaspargase) is L-asparaginase (L-asparagine amidohydrolase) that is covale...

  • Indications
  • First Line Acute Lymphoblastic Leukemia (ALL) Oncaspar® is indicated as a component of a multi-agent chemotherapeutic regimen for the first line treatment of patients
  •   Read More
Oncaspar pegaspargase (Pronunciation: peg ah SPAR jase - Multum

Description : Oncaspar® (pegaspargase) is L-asparaginase (L-asparagine amidohydrolase) that is covale...

  • Indications
  • First Line Acute Lymphoblastic Leukemia (ALL) Oncaspar® is indicated as a component of a multi-agent chemotherapeutic regimen for the first line treatment of patients
  •   Read More
Oncovin, Vincasar PFS vincristine (Pronunciation: vin KRIS teen) - FDA

Description : VINCASAR PFS® (vincristine sulfate injection, USP) is the salt of an alkaloidobta...

  • Indications
  • VINCASAR PFS (vincristine sulfate injection) Injection is indicated in acute leukemia. VINCASAR PFS (vincristine sulfate injection) Injection has also been shown to be u
  •   Read More
Oncovin, Vincasar PFS vincristine (Pronunciation: vin KRIS teen) - Multum

Description : VINCASAR PFS® (vincristine sulfate injection, USP) is the salt of an alkaloidobta...

  • Indications
  • VINCASAR PFS (vincristine sulfate injection) Injection is indicated in acute leukemia. VINCASAR PFS (vincristine sulfate injection) Injection has also been shown to be u
  •   Read More
Oncovin, Vincasar PFS vincristine (Pronunciation: vin KRIS teen) - FDA

Description : VINCASAR PFS® (vincristine sulfate injection, USP) is the salt of an alkaloidobta...

  • Indications
  • VINCASAR PFS (vincristine sulfate injection) Injection is indicated in acute leukemia. VINCASAR PFS (vincristine sulfate injection) Injection has also been shown to be u
  •   Read More
Oncovin, Vincasar PFS vincristine (Pronunciation: vin KRIS teen) - Multum

Description : VINCASAR PFS® (vincristine sulfate injection, USP) is the salt of an alkaloidobta...

  • Indications
  • VINCASAR PFS (vincristine sulfate injection) Injection is indicated in acute leukemia. VINCASAR PFS (vincristine sulfate injection) Injection has also been shown to be u
  •   Read More
Oncovin, Vincasar PFS vincristine (Pronunciation: vin KRIS teen) - FDA

Description : VINCASAR PFS® (vincristine sulfate injection, USP) is the salt of an alkaloidobta...

  • Indications
  • VINCASAR PFS (vincristine sulfate injection) Injection is indicated in acute leukemia. VINCASAR PFS (vincristine sulfate injection) Injection has also been shown to be u
  •   Read More
Oncovin, Vincasar PFS vincristine (Pronunciation: vin KRIS teen) - Multum

Description : VINCASAR PFS® (vincristine sulfate injection, USP) is the salt of an alkaloidobta...

  • Indications
  • VINCASAR PFS (vincristine sulfate injection) Injection is indicated in acute leukemia. VINCASAR PFS (vincristine sulfate injection) Injection has also been shown to be u
  •   Read More
Onexton (clindamycin phosphate and benzoyl peroxide) Gel - FDA

Description : ONEXTON Gel is a combination product with two active ingredients in a white to off-white, o...

  • Indications
  • ONEXTON™ (clindamycin phosphate and benzoyl peroxide) Gel, 1.2%/3.75% is indicated for the topical treatment of acne vulgaris in patients 12 years of age and older.
  •   Read More
Onexton clindamycin phosphate and benzoyl peroxide) Gel - FDA

Description : ONEXTON Gel is a combination product with two active ingredients in a white to off-white, o...

  • Indications
  • ONEXTON™ (clindamycin phosphate and benzoyl peroxide) Gel, 1.2%/3.75% is indicated for the topical treatment of acne vulgaris in patients 12 years of age and older.
  •   Read More
Onfi clobazam (Pronunciation: KLOE ba zam) - FDA

Description : Table 4: Description Proprietary Name: ONFI® Established Name: Clobazam...

  • Indications
  • ONFI® (clobazam) is indicated for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients 2 years of age or older.
  •   Read More
Onfi clobazam (Pronunciation: KLOE ba zam) - Multum

Description : Table 4: Description Proprietary Name: ONFI® Established Name: Clobazam...

  • Indications
  • ONFI® (clobazam) is indicated for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients 2 years of age or older.
  •   Read More
Onfi clobazam) Tablets and Oral Suspension - FDA

Description : Table 4: Description Proprietary Name: ONFI® Established Name: Clobazam...

  • Indications
  • ONFI® (clobazam) is indicated for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients 2 years of age or older.
  •   Read More
Onfi clobazam (Pronunciation: KLOE ba zam) - Multum

Description : Table 4: Description Proprietary Name: ONFI® Established Name: Clobazam...

  • Indications
  • ONFI® (clobazam) is indicated for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients 2 years of age or older.
  •   Read More
Onglyza saxagliptin (Pronunciation: SAX a GLIP tin) - FDA

Description : Saxagliptin is an orally-active inhibitor of the DPP4 enzyme. Saxagliptin monohydrate is d...

  • Indications
  • Monotherapy and Combination Therapy ONGLYZA is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus in multipl
  •   Read More
Onglyza saxagliptin (Pronunciation: SAX a GLIP tin) - Multum

Description : Saxagliptin is an orally-active inhibitor of the DPP4 enzyme. Saxagliptin monohydrate is d...

  • Indications
  • Monotherapy and Combination Therapy ONGLYZA is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus in multipl
  •   Read More
Onglyza saxagliptin (Pronunciation: SAX a GLIP tin) - FDA

Description : Saxagliptin is an orally-active inhibitor of the DPP4 enzyme. Saxagliptin monohydrate is descr...

  • Indications
  • Monotherapy and Combination Therapy ONGLYZA is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus in m
  •   Read More
Onglyza saxagliptin (Pronunciation: SAX a GLIP tin) - Multum

Description : Saxagliptin is an orally-active inhibitor of the DPP4 enzyme. Saxagliptin monohydrate is descr...

  • Indications
  • Monotherapy and Combination Therapy ONGLYZA is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus in m
  •   Read More
Onmel, Sporanox, Sporanox PulsePak itraconazole (Pronunciation: IT ra KON a zole - FDA

Description : SPORANOX® is the brand name for itraconazole, a synthetic triazole antifungal agent. It...

  • Indications
  • SPORANOX® (itraconazole) Capsules are indicated for the treatment of the following fungal infections in immunocompromised and non-immunocompromised patients: Blasto
  •   Read More
Onmel, Sporanox, Sporanox PulsePak itraconazole (Pronunciation: IT ra KON a zole - Multum

Description : SPORANOX® is the brand name for itraconazole, a synthetic triazole antifungal agent. It...

  • Indications
  • SPORANOX® (itraconazole) Capsules are indicated for the treatment of the following fungal infections in immunocompromised and non-immunocompromised patients: Blasto
  •   Read More
Onmel, Sporanox, Sporanox PulsePak  itraconazole (Pronunciation: IT ra KON a zole) - Multum

Description : SPORANOX® is the brand name for itraconazole, a synthetic triazole antifungal agent. It...

  • Indications
  • SPORANOX® (itraconazole) Oral Solution is indicated for the treatment of oropharyngeal and esophageal candidiasis. (See CLINICAL PHARMACOLOGY: Special Populations, WARNING
  •   Read More
Onmel, Sporanox, Sporanox PulsePak  itraconazole (Pronunciation: IT ra KON a zole) - FDA

Description : SPORANOX® is the brand name for itraconazole, an azole antifungal agent. Itraconazole is a ...

  • Indications
  • SPORANOX® (itraconazole) Capsules are indicated for the treatment of the following fungal infections in immunocompromised and non-immunocompromised patients: Blasto
  •   Read More
Onmel, Sporanox, Sporanox PulsePak itraconazole (Pronunciation: IT ra KON a zole) - Multum

Description : SPORANOX® is the brand name for itraconazole, an azole antifungal agent. Itraconazole is a ...

  • Indications
  • SPORANOX® (itraconazole) Capsules are indicated for the treatment of the following fungal infections in immunocompromised and non-immunocompromised patients: Blasto
  •   Read More
Onmel, Sporanox, Sporanox PulsePak  itraconazole (Pronunciation: IT ra KON a zole) - FDA

Description : SPORANOX® is the brand name for itraconazole, a synthetic triazole antifungal agent. Itraco...

  • Indications
  • SPORANOX® (itraconazole) Oral Solution is indicated for the treatment of oropharyngeal and esophageal candidiasis. (See CLINICAL PHARMACOLOGY: Special Populations, WAR
  •   Read More
Ontak denileukin diftitox (Pronunciation: de ni LOO kin - FDA

Description : Ontak (denileukin diftitox), is a recombinant DNA-derived cytotoxic protein composed of the...

  • Indications
  • Ontak® (denileukin diftitox) is indicated for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma whose malignant cells express the CD25 compo
  •   Read More
Ontak denileukin diftitox (Pronunciation: de ni LOO kin - Multum

Description : Ontak (denileukin diftitox), is a recombinant DNA-derived cytotoxic protein composed of the...

  • Indications
  • Ontak® (denileukin diftitox) is indicated for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma whose malignant cells express the CD25 compo
  •   Read More
Ontak denileukin diftitox (Pronunciation: de ni LOO kin - FDA

Description : Ontak (denileukin diftitox), is a recombinant DNA-derived cytotoxic protein composed of the...

  • Indications
  • Ontak® (denileukin diftitox) is indicated for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma whose malignant cells express the CD25 compo
  •   Read More
Ontak denileukin diftitox (Pronunciation: de ni LOO kin - Multum

Description : Ontak (denileukin diftitox), is a recombinant DNA-derived cytotoxic protein composed of the...

  • Indications
  • Ontak® (denileukin diftitox) is indicated for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma whose malignant cells express the CD25 compo
  •   Read More
Onxol paclitaxel (Pronunciation: PAK li TAK sel) - FDA

Description : TAXOL (paclitaxel) Injection is a clear, colorless to slightly yellow viscous solution. It ...

  • Indications
  • TAXOL is indicated as first-line and subsequent therapy for the treatment of advanced carcinoma of the ovary. As first-line therapy, TAXOL is indicated in combination with
  •   Read More
Onxol paclitaxel (Pronunciation: PAK li TAK sel) - Multum

Description : TAXOL (paclitaxel) Injection is a clear, colorless to slightly yellow viscous solution. It ...

  • Indications
  • TAXOL is indicated as first-line and subsequent therapy for the treatment of advanced carcinoma of the ovary. As first-line therapy, TAXOL is indicated in combination with
  •   Read More
Onxol paclitaxel (Pronunciation: PAK li TAK sel) - Multum

Description : TAXOL (paclitaxel) Injection is a clear, colorless to slightly yellow viscous solution. It ...

  • Indications
  • TAXOL is indicated as first-line and subsequent therapy for the treatment of advanced carcinoma of the ovary. As first-line therapy, TAXOL is indicated in combination with
  •   Read More
Opana, Opana ER oxymorphone (Pronunciation: ox ee MOR fone) - FDA

Description : OPANA (oxymorphone hydrochloride) is a semi-synthetic opioid analgesic supplied in 5 mg and...

  • Indications
  • OPANA (oxymorphone hydrochloride) is indicated for the relief of moderate to severe acute pain where the use of an opioid is appropriate.
  •   Read More
Opana, Opana ER  oxymorphone (Pronunciation: ox ee MOR fone) - FDA

Description : OPANA ER extended-release tablets are for oral use and contain oxymorphone, a semi-syntheti...

  • Indications
  • OPANA ER is indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options a
  •   Read More
Opana, Opana ER oxymorphone (Pronunciation: ox ee MOR fone - Multum

Description : OPANA ER extended-release tablets are for oral use and contain oxymorphone, a semi-syntheti...

  • Indications
  • OPANA ER is indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options a
  •   Read More
Opana, Opana ER oxymorphone (Pronunciation: ox ee MOR fone) - FDA

Description : OPANA (oxymorphone hydrochloride) is a semi-synthetic opioid analgesic supplied in 5 mg and...

  • Indications
  • OPANA (oxymorphone hydrochloride) is indicated for the relief of moderate to severe acute pain where the use of an opioid is appropriate.
  •   Read More
Opana, Opana ER oxymorphone (Pronunciation: ox ee MOR fone) - Multum

Description : OPANA (oxymorphone hydrochloride) is a semi-synthetic opioid analgesic supplied in 5 mg and...

  • Indications
  • OPANA (oxymorphone hydrochloride) is indicated for the relief of moderate to severe acute pain where the use of an opioid is appropriate.
  •   Read More
Opana, Opana ER oxymorphone (Pronunciation: ox ee MOR fone) - FDA

Description : OPANA ER extended-release tablets are for oral use and contain oxymorphone, a semi-syntheti...

  • Indications
  • OPANA ER is indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options a
  •   Read More
Opana, Opana ER oxymorphone (Pronunciation: ox ee MOR fone - Multum

Description : OPANA ER extended-release tablets are for oral use and contain oxymorphone, a semi-syntheti...

  • Indications
  • OPANA ER is indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options a
  •   Read More
Opdivo nivolumab) for Injection - FDA

Description : Nivolumab is a human monoclonal antibody that blocks the interaction between PD-1 and its l...

  • Indications
  • OPDIVO® (nivolumab) is indicated for the treatment of patients with unresectable or metastatic melanoma and disease progression following ipilimumab and, if BRAF V600
  •   Read More
Opdivo (nivolumab) for Injection - FDA

Description : Nivolumab is a human monoclonal antibody that blocks the interaction between PD-1 and its l...

  • Indications
  • OPDIVO® (nivolumab) is indicated for the treatment of patients with unresectable or metastatic melanoma and disease progression following ipilimumab and, if BRAF V600
  •   Read More
Opium Deodorized, Paregoric  opium preparation (Pronunciation: OH pee um) - Multum

Description : PAREGORIC (anhydrous morphine) , USP(anhydrous morphine) Each 5 mL (one teaspoonful) contain...

  • Indications
  • Paregoric (anhydrous morphine) is useful for the treatment of diarrhea.
  •   Read More
Opium Deodorized, Paregoric opium preparation (Pronunciation: OH pee um - Multum

Description : PAREGORIC (anhydrous morphine) , USP(anhydrous morphine) Each 5 mL (one teaspoonful) contain...

  • Indications
  • Paregoric (anhydrous morphine) is useful for the treatment of diarrhea.
  •   Read More
Opsumit (macitentan) Tablets - FDA

Description : OPSUMIT (macitentan) is an endothelin receptor antagonist. The chemical name of macitentan...

  • Indications
  • Pulmonary Arterial Hypertension OPSUMIT® is an endothelin receptor antagonist (ERA) indicated for the treatment of pulmonary arterial hypertension (PA
  •   Read More
Opsumit macitentan) Tablets - FDA

Description : OPSUMIT (macitentan) is an endothelin receptor antagonist. The chemical name of macitentan...

  • Indications
  • Pulmonary Arterial Hypertension OPSUMIT® is an endothelin receptor antagonist (ERA) indicated for the treatment of pulmonary arterial hypertension (PAH, WHO Group I)
  •   Read More
OptiMARK gadoversetamide (Pronunciation: GAD oh ver SET a m - Multum

Description : OptiMARK (gadoversetamide) injection is a nonionic gadolinium chelate of diethylenetriamine...

  • Indications
  • MRI Of Central Nervous System (CNS) OptiMARK is indicated for use with magnetic resonance imaging (MRI) in patients with abnormal blood-brain barrier or abnormal vascular
  •   Read More
OptiMARK gadoversetamide) Injection - FDA

Description : OptiMARK (gadoversetamide) injection is a nonionic gadolinium chelate of diethylenetriamine...

  • Indications
  • MRI Of Central Nervous System (CNS) OptiMARK is indicated for use with magnetic resonance imaging (MRI) in patients with abnormal blood-brain barrier or abnormal vascular
  •   Read More
OptiMARK gadoversetamide (Pronunciation: GAD oh ver SET a m - Multum

Description : OptiMARK (gadoversetamide) injection is a nonionic gadolinium chelate of diethylenetriamine...

  • Indications
  • MRI Of Central Nervous System (CNS) OptiMARK is indicated for use with magnetic resonance imaging (MRI) in patients with abnormal blood-brain barrier or abnormal vascular
  •   Read More
OptiPranolol metipranolol ophthalmic (Pronunciation: MET i PRAN - FDA

Description : OptiPranolol® (metipranolol ophthalmic solution) 0.3% contains metipranolol, a non-sele...

  • Indications
  • OptiPranolol (metipranolol ophthalmic solution) Ophthalmic Solution is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open
  •   Read More
OptiPranolol metipranolol ophthalmic (Pronunciation: MET i PRAN - Multum

Description : OptiPranolol® (metipranolol ophthalmic solution) 0.3% contains metipranolol, a non-sele...

  • Indications
  • OptiPranolol (metipranolol ophthalmic solution) Ophthalmic Solution is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open
  •   Read More
OptiPranolol metipranolol ophthalmic (Pronunciation: MET i PRAN - FDA

Description : OptiPranolol® (metipranolol ophthalmic solution) 0.3% contains metipranolol, a non-selectiv...

  • Indications
  • OptiPranolol (metipranolol ophthalmic solution) Ophthalmic Solution is indicated in the treatment of elevated intraocular pressure in patients with ocular
  •   Read More
OptiPranolol metipranolol ophthalmic (Pronunciation: MET i PRAN - Multum

Description : OptiPranolol® (metipranolol ophthalmic solution) 0.3% contains metipranolol, a non-selectiv...

  • Indications
  • OptiPranolol (metipranolol ophthalmic solution) Ophthalmic Solution is indicated in the treatment of elevated intraocular pressure in patients with ocular
  •   Read More
Optiray 160, Optiray 240, Optiray 300, Optiray 320, Optiray 350 ioversol (Pronunciation: eye oh VERS ol) - FDA

Description : OPTIRAY (ioversol injection) formulations are sterile, nonpyrogenic, aqueous solutions inte...

  • Indications
  • OPTIRAY 350 is indicated in adults for peripheral and coronary arteriography and left ventriculography. OPTIRAY 350 is also indicated for contrast enhanced computed tomogr
  •   Read More
Optiray 160, Optiray 240, Optiray 300, Optiray 320, Optiray 350  ioversol (Pronunciation: eye oh VERS ol) - Multum

Description : OPTIRAY (ioversol injection) formulations are sterile, nonpyrogenic, aqueous solutions inte...

  • Indications
  • OPTIRAY 350 is indicated in adults for peripheral and coronary arteriography and left ventriculography. OPTIRAY 350 is also indicated for contrast enhanced computed tomogr
  •   Read More
Optiray 160, Optiray 240, Optiray 300, Optiray 320, Optiray 350 ioversol (Pronunciation: eye oh VERS ol - FDA

Description : OPTIRAY (ioversol injection) formulations are sterile, nonpyrogenic, aqueous solutions inte...

  • Indications
  • OPTIRAY 350 is indicated in adults for peripheral and coronary arteriography and left ventriculography. OPTIRAY 350 is also indicated for contrast enhanced computed tomogr
  •   Read More
Optiray 160, Optiray 240, Optiray 300, Optiray 320, Optiray 350 ioversol (Pronunciation: eye oh VERS ol) - Multum

Description : OPTIRAY (ioversol injection) formulations are sterile, nonpyrogenic, aqueous solutions inte...

  • Indications
  • OPTIRAY 350 is indicated in adults for peripheral and coronary arteriography and left ventriculography. OPTIRAY 350 is also indicated for contrast enhanced computed tomogr
  •   Read More
Optison Perflutren Protein-Type A Microspheres) Injectable - FDA

Description : OPTISON™ (Perflutren Protein-Type A Microspheres Injectable Suspension, USP) is a ste...

  • Indications
  • OPTISON is indicated for use in patients with suboptimal echocardiograms to opacify the left ventricle and to improve the delineation of the left ventricular endocardial borde
  •   Read More
Optison Perflutren Protein-Type A Microspheres) Injectable - FDA

Description : OPTISON™ (Perflutren Protein-Type A Microspheres Injectable Suspension, USP) is a ste...

  • Indications
  • OPTISON is indicated for use in patients with suboptimal echocardiograms to opacify the left ventricle and to improve the delineation of the left ventricular endocardial borde
  •   Read More
Optivar azelastine ophthalmic (Pronunciation: a ZEL as tee - Multum

Description : OPTIVAR® (azelastine hydrochloride ophthalmic solution), 0.05% is a sterile ophthalmic ...

  • Indications
  • OPTIVAR (azelastine hydrochloride) ® is indicated for the treatment of itching of the eye associated with allergic conjunctivitis.
  •   Read More
Optivar azelastine ophthalmic (Pronunciation: a ZEL as tee - FDA

Description : OPTIVAR® (azelastine hydrochloride ophthalmic solution), 0.05% is a sterile ophthalmic ...

  • Indications
  • OPTIVAR (azelastine hydrochloride) ® is indicated for the treatment of itching of the eye associated with allergic conjunctivitis.
  •   Read More
Optivar azelastine ophthalmic (Pronunciation: a ZEL as tee - Multum

Description : OPTIVAR® (azelastine hydrochloride ophthalmic solution), 0.05% is a sterile ophthalmic ...

  • Indications
  • OPTIVAR (azelastine hydrochloride) ® is indicated for the treatment of itching of the eye associated with allergic conjunctivitis.
  •   Read More
Oralair Sweet Vernal, Orchard, Perennial Rye, Timothy, and - FDA

Description : ORALAIR (Sweet Vernal, Orchard, Perennial Rye, Timothy, and Kentucky Blue Grass Mixed Polle...

  • Indications
  • ORALAIR is an allergen extract indicated as immunotherapy for the treatment of grass pollen-induced allergic rhinitis with or without conjunctivitis confirmed by positiv
  •   Read More
Oralair (Sweet Vernal, Orchard, Perennial Rye, Timothy, an - FDA

Description : ORALAIR (Sweet Vernal, Orchard, Perennial Rye, Timothy, and Kentucky Blue Grass Mixed Pollens A...

  • Indications
  • ORALAIR is an allergen extract indicated as immunotherapy for the treatment of grass pollen-induced allergic rhinitis with or without conjunctivitis confirmed by positiv
  •   Read More
Orap pimozide (Pronunciation: PIM oh zide) - Multum

Description : ORAP® (pimozide) is an orally active antipsychotic agent of the diphenyl-butylpiperidin...

  • Indications
  • ORAP (pimozide) is indicated for the suppression of motor and phonic tics in patients with Tourette's Disorder who have failed to respond satisfactorily to standard treatm
  •   Read More
Orap pimozide (Pronunciation: PIM oh zide) - FDA

Description : ORAP® (pimozide) is an orally active antipsychotic agent of the diphenyl-butylpiperidin...

  • Indications
  • ORAP (pimozide) is indicated for the suppression of motor and phonic tics in patients with Tourette's Disorder who have failed to respond satisfactorily to standard treatm
  •   Read More
Orap pimozide (Pronunciation: PIM oh zide) - Multum

Description : ORAP® (pimozide) is an orally active antipsychotic agent of the diphenyl-butylpiperidin...

  • Indications
  • ORAP (pimozide) is indicated for the suppression of motor and phonic tics in patients with Tourette's Disorder who have failed to respond satisfactorily to standard treatm
  •   Read More
Oraqix (lidocaine and prilocaine) Periodontal Gel - FDA

Description : Oraqix (lidocaine and prilocaine periodontal gel,) 2.5%/2.5% is a microemulsion in which th...

  • Indications
  • Oraqix is an amide local anesthetic indicated for adults who require localized anesthesia in periodontal pockets during scaling and/or root planing.
  •   Read More
Oraqix (lidocaine and prilocaine) Periodontal Gel - FDA

Description : Oraqix (lidocaine and prilocaine periodontal gel,) 2.5%/2.5% is a microemulsion in which th...

  • Indications
  • Oraqix is an amide local anesthetic indicated for adults who require localized anesthesia in periodontal pockets during scaling and/or root planing.
  •   Read More
OraVerse phentolamine mesylate) Injection - FDA

Description : Phentolamine mesylate is phenol,3-[[(4,5-dihydro-1H-imidazol-2-yl)methyl](4-methyl-phenyl)a...

  • Indications
  • OraVerse is indicated for reversal of the soft-tissue anesthesia, i.e., anesthesia of the lip and tongue, and the associated functional deficits resulting from an intraoral s
  •   Read More
OraVerse  (phentolamine mesylate) Injection - FDA

Description : Phentolamine mesylate is phenol,3-[[(4,5-dihydro-1H-imidazol-2-yl)methyl](4-methyl-phenyl)a...

  • Indications
  • OraVerse is indicated for reversal of the soft-tissue anesthesia, i.e., anesthesia of the lip and tongue, and the associated functional deficits resulting from an intraoral s
  •   Read More
ORAVIG miconazole oral (buccal) (Pronunciation: mye KON a - FDA

Description : ORAVIG (miconazole) buccal tablets are applied topically to the gum once daily and release ...

  • Indications
  • ORAVIG is indicated for the local treatment of oropharyngeal candidiasis (OPC) in adults.
  •   Read More
ORAVIG miconazole oral (buccal) (Pronunciation: mye KON a - Multum

Description : ORAVIG (miconazole) buccal tablets are applied topically to the gum once daily and release ...

  • Indications
  • ORAVIG is indicated for the local treatment of oropharyngeal candidiasis (OPC) in adults.
  •   Read More
ORAVIG miconazole oral (buccal) (Pronunciation: mye KON a - FDA

Description : ORAVIG (miconazole) buccal tablets are applied topically to the gum once daily and release mico...

  • Indications
  • ORAVIG is indicated for the local treatment of oropharyngeal candidiasis(OPC) in adults.
  •   Read More
ORAVIG miconazole oral (buccal) (Pronunciation: mye KON a - Multum

Description : ORAVIG (miconazole) buccal tablets are applied topically to the gum once daily and release mico...

  • Indications
  • ORAVIG is indicated for the local treatment of oropharyngeal candidiasis(OPC) in adults.
  •   Read More
Orbactiv (oritavancin) for Injection - FDA

Description : ORBACTIV (oritavancin) for injection contains oritavancin diphosphate, a semisynthetic lipo...

  • Indications
  • Acute Bacterial Skin And Skin Structure Infections ORBACTIV™ (Oritavancin) for injection is indicated for the treatment of adult patients with acute bacterial skin
  •   Read More
Orbactiv oritavancin) for Injection - FDA

Description : ORBACTIV (oritavancin) for injection contains oritavancin diphosphate, a semisynthetic lipo...

  • Indications
  • Acute Bacterial Skin And Skin Structure Infections ORBACTIV™ (Oritavancin) for injection is indicated for the treatment of adult patients with acute bacterial skin
  •   Read More
Orbivan (butalbital, acetaminophen, and caffeine) Capsules - FDA

Description : ORBIVAN™ Butalbital, Acetaminophen and Caffeine Capsules, USP are supplied in hard-ge...

  • Indications
  • ORBIVAN™ Butalbital, Acetaminophen and Caffeine Capsules, USP are indicated for the relief of the symptom complex of tension (or muscle contraction) headache. Evide
  •   Read More
Orbivan butalbital, acetaminophen, and caffeine) Capsules, - FDA

Description : ORBIVAN™ Butalbital, Acetaminophen and Caffeine Capsules, USP are supplied in hard-ge...

  • Indications
  • ORBIVAN™ Butalbital, Acetaminophen and Caffeine Capsules, USP are indicated for the relief of the symptom complex of tension (or muscle contraction) headache. Evide
  •   Read More
ORENCIA  (abatacept) Injection and Lyophilized Powder for I - FDA

Description : ORENCIA® (abatacept) is a soluble fusion protein that consists of the extracellular domain ...

  • Indications
  • Adult Rheumatoid Arthritis (RA) ORENCIA® is indicated for reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural dama
  •   Read More
Orencia  abatacept (Pronunciation: a BAY ta sept) - Multum

Description : ORENCIA® (abatacept) is a soluble fusion protein that consists of the extracellular domain ...

  • Indications
  • Adult Rheumatoid Arthritis (RA) ORENCIA® is indicated for reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural dama
  •   Read More
Orencia abatacept (Pronunciation: a BAY ta sept) - FDA

Description : ORENCIA® (abatacept) is a soluble fusion protein that consists of the extracellular do...

  • Indications
  • Adult Rheumatoid Arthritis (RA) ORENCIA® is indicated for reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural dama
  •   Read More
Orencia abatacept (Pronunciation: a BAY ta sept) - Multum

Description : ORENCIA® (abatacept) is a soluble fusion protein that consists of the extracellular do...

  • Indications
  • Adult Rheumatoid Arthritis (RA) ORENCIA® is indicated for reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural dama
  •   Read More
Orenitram (treprostinil) Extended Release Osmotic Tablets fo - FDA

Description : Orenitram is an extended release osmotic tablet for oral administration. Orenitram is formulate...

  • Indications
  • Pulmonary Arterial Hypertension Orenitram is indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise capacity. The study that e
  •   Read More
Orenitram treprostinil) Extended Release Osmotic Tablets for - FDA

Description : Orenitram is an extended release osmotic tablet for oral administration. Orenitram is formu...

  • Indications
  • Pulmonary Arterial Hypertension Orenitram is indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise capacity. The study th
  •   Read More
Orfadin nitisinone (Pronunciation: ni TIZ i none) - FDA

Description : ORFADIN contains nitisinone, which is a hydroxyphenyl-pyruvate dioxygenase inhibitor indica...

  • Indications
  • ORFADIN® capsules (nitisinone) are indicated as an adjunct to dietary restriction of tyrosine and phenylalanine in the treatment of patients with hereditary tyrosinem
  •   Read More
Orfadin nitisinone (Pronunciation: ni TIZ i none) - Multum

Description : ORFADIN contains nitisinone, which is a hydroxyphenyl-pyruvate dioxygenase inhibitor indica...

  • Indications
  • ORFADIN® capsules (nitisinone) are indicated as an adjunct to dietary restriction of tyrosine and phenylalanine in the treatment of patients with hereditary tyrosinem
  •   Read More
Orfadin nitisinone (Pronunciation: ni TIZ i none) - FDA

Description : ORFADIN contains nitisinone, which is a hydroxyphenyl-pyruvate dioxygenase inhibitor indica...

  • Indications
  • ORFADIN® capsules (nitisinone) are indicated as an adjunct to dietary restriction of tyrosine and phenylalanine in the treatment of patients with hereditary tyrosinemia t
  •   Read More
Orfadin nitisinone (Pronunciation: ni TIZ i none) - Multum

Description : ORFADIN contains nitisinone, which is a hydroxyphenyl-pyruvate dioxygenase inhibitor indica...

  • Indications
  • ORFADIN® capsules (nitisinone) are indicated as an adjunct to dietary restriction of tyrosine and phenylalanine in the treatment of patients with hereditary tyrosinemia t
  •   Read More
Orimune Oral poliovirus vaccine - FDA

Description : Oral poliovirus vaccine (OPV) contains live attenuated poliovirus (Sabin strain types 1, 2 ...

  • Indications
  • For poliovirus prophylaxis: Adults: 0.5 mL PO initially, then repeated 8 weeks later. The third dose should be given 8-12 months after the second dose. When less than 4 w
  •   Read More
Orimune Oral poliovirus vaccine - FDA

Description : Oral poliovirus vaccine (OPV) contains live attenuated poliovirus (Sabin strain types 1, 2 ...

  • Indications
  • For poliovirus prophylaxis: Adults: 0.5 mL PO initially, then repeated 8 weeks later. The third dose should be given 8-12 months after the second dose. When less than 4 w
  •   Read More
Orlaam (levomethadyl acetate hydrochloride) - FDA

Description : ORLAAM (levomethadyl acetate) (brand of levomethadyl acetate hydrochloride) is a synthetic ...

  • Indications
  • ORLAAM (levomethadyl acetate) is indicated for the management of opiate dependence. ORLAAM (levomethadyl acetate) should be reserved for the use in treatment of opiate-addicte
  •   Read More
Orlaam levomethadyl acetate hydrochloride - FDA

Description : ORLAAM (levomethadyl acetate) (brand of levomethadyl acetate hydrochloride) is a synthetic ...

  • Indications
  • ORLAAM (levomethadyl acetate) is indicated for the management of opiate dependence. ORLAAM (levomethadyl acetate) should be reserved for the use in treatment of opiate-addicte
  •   Read More
Orphengesic Orphengesic (orphenadrine citrate, aspirin and caf - FDA

Description : Each Orphengesic (orphenadrine citrate, asprin and caffeine tablets) Tablet, for oral admin...

  • Indications
  • Orphengesic (orphenadrine citrate, asprin and caffeine tablets) (Orphenadrine Citrate, Aspirin and Caffeine 25mg/385mg/30 mg) and Orphengesic (orphenadrine citrate, asprin
  •   Read More
Orphengesic Orphengesic (orphenadrine citrate, aspirin and caf - FDA

Description : Each Orphengesic (orphenadrine citrate, asprin and caffeine tablets) Tablet, for oral admin...

  • Indications
  • Each Orphengesic (orphenadrine citrate, asprin and caffeine tablets) Tablet, for oral administration contains Orphenadrine Citrate 25mg, Aspirin 385mg and Caffeine 30 mg.
  •   Read More
Ortho Evra ethinyl estradiol and norelgestromin (transdermal) - Multum

Description : ORTHO EVRA is a combination transdermal contraceptive system with a contact surface area of...

  • Indications
  • ORTHO EVRA is indicated for the prevention of pregnancy in women who elect to use a transdermal patch as a method of contraception. Limitation of Use ORTHO EVRA may be
  •   Read More
Ortho Evra ethinyl estradiol and norelgestromin (transdermal) - FDA

Description : ORTHO EVRA is a combination transdermal contraceptive system with a contact surface area of...

  • Indications
  • ORTHO EVRA is indicated for the prevention of pregnancy in women who elect to use a transdermal patch as a method of contraception. Limitation of Use ORTHO EVRA may be
  •   Read More
Ortho Evra ethinyl estradiol and norelgestromin (transdermal) - Multum

Description : ORTHO EVRA is a combination transdermal contraceptive system with a contact surface area of...

  • Indications
  • ORTHO EVRA is indicated for the prevention of pregnancy in women who elect to use a transdermal patch as a method of contraception. Limitation of Use ORTHO EVRA may be
  •   Read More
Oseni (alogliptin and pioglitazone) Tablets - FDA

Description : OSENI tablets contain 2 oral antihyperglycemic drugs used in the management of type 2 diabe...

  • Indications
  • Monotherapy and Combination Therapy OSENI is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus in multiple
  •   Read More
Oseni alogliptin and pioglitazone) Tablets - FDA

Description : OSENI tablets contain 2 oral antihyperglycemic drugs used in the management of type 2 diabe...

  • Indications
  • Monotherapy and Combination Therapy OSENI is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus in multiple
  •   Read More
Osmitrol mannitol (Pronunciation: MAN it ol) - FDA

Description : Osmitrol Injection (Mannitol Injection, USP) is a sterile, nonpyrogenic solution of Mannitol, U...

  • Indications
  • Osmitrol Injection (Mannitol Injection, USP) is indicated for: The promotion of diuresis, in the prevention and/or treatment of the oliguric phase of acute renal fa
  •   Read More
Osmitrol mannitol (Pronunciation: MAN it ol) - Multum

Description : Osmitrol Injection (Mannitol Injection, USP) is a sterile, nonpyrogenic solution of Mannitol, U...

  • Indications
  • Osmitrol Injection (Mannitol Injection, USP) is indicated for: The promotion of diuresis, in the prevention and/or treatment of the oliguric phase of acute renal fa
  •   Read More
Osmitrol mannitol (Pronunciation: MAN it ol) - FDA

Description : OSMITROL Injection (Mannitol Injection, USP) is a sterile, nonpyrogenic solution of Manni...

  • Indications
  • OSMITROL Injection (Mannitol Injection, USP) is indicated for: The promotion of diuresis, in the prevention and/or treatment of the oliguric phase of acute renal fa
  •   Read More
Osmitrol mannitol (Pronunciation: MAN it ol) - Multum

Description : OSMITROL Injection (Mannitol Injection, USP) is a sterile, nonpyrogenic solution of Manni...

  • Indications
  • OSMITROL Injection (Mannitol Injection, USP) is indicated for: The promotion of diuresis, in the prevention and/or treatment of the oliguric phase of acute renal fa
  •   Read More
Osmitrol mannitol (Pronunciation: MAN it ol) - FDA

Description : Osmitrol Injection (Mannitol Injection, USP) is a sterile, nonpyrogenic solution of Mannito...

  • Indications
  • Osmitrol Injection (Mannitol Injection, USP) is indicated for: The promotion of diuresis, in the prevention and/or treatment of the oliguric phase of acute renal failure
  •   Read More
Osmitrol mannitol (Pronunciation: MAN it ol) - Multum

Description : Osmitrol Injection (Mannitol Injection, USP) is a sterile, nonpyrogenic solution of Mannito...

  • Indications
  • Osmitrol Injection (Mannitol Injection, USP) is indicated for: The promotion of diuresis, in the prevention and/or treatment of the oliguric phase of acute renal failure
  •   Read More
Osmitrol mannitol (Pronunciation: MAN it ol) - FDA

Description : OSMITROL Injection (Mannitol Injection, USP) is a sterile, nonpyrogenic solution of Mannito...

  • Indications
  • OSMITROL Injection (Mannitol Injection, USP) is indicated for: The promotion of diuresis, in the prevention and/or treatment of the oliguric phase of acute renal failure
  •   Read More
Osmitrol mannitol (Pronunciation: MAN it ol) - Multum

Description : OSMITROL Injection (Mannitol Injection, USP) is a sterile, nonpyrogenic solution of Mannito...

  • Indications
  • OSMITROL Injection (Mannitol Injection, USP) is indicated for: The promotion of diuresis, in the prevention and/or treatment of the oliguric phase of acute renal failure
  •   Read More
Osmitrol Injection in Viaflex mannitol) Injection, USP in VIAFLEX Plastic Contai - FDA

Description : OSMITROL Injection (Mannitol Injection, USP) is a sterile, nonpyrogenic solution of Mannito...

  • Indications
  • OSMITROL Injection (Mannitol Injection, USP) is indicated for: The promotion of diuresis, in the prevention and/or treatment of the oliguric phase of acute renal failure
  •   Read More
Osphena (ospemifene) Tablets - FDA

Description : OSPHENA is an estrogen agonist/antagonist. The chemical structure of ospemifene is shown in...

  • Indications
  • OSPHENA is indicated for the treatment of moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy, due to menopause.
  •   Read More
Osphena ospemifene) Tablets - FDA

Description : OSPHENA is an estrogen agonist/antagonist. The chemical structure of ospemifene is shown in...

  • Indications
  • OSPHENA is indicated for the treatment of moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy, due to menopause.
  •   Read More
Otezla (apremilast) Tablets - FDA

Description : The active ingredient in OTEZLA tablets is apremilast. Apremilast is a phosphodiesterase 4 ...

  • Indications
  • Psoriatic Arthritis OTEZLA is indicated for the treatment of adult patients with active psoriatic arthritis. Psoriasis OTEZLA is indicated for the treatment of patients
  •   Read More
Otezla Apremilast Tablets - FDA

Description : Psoriatic Arthritis OTEZLA is indicated for the treatment of adult patients with active ps...

  • Indications
  • Psoriatic Arthritis OTEZLA is indicated for the treatment of adult patients with active psoriatic arthritis. Psoriasis OTEZLA is indicated for the treatment of patients
  •   Read More
Otrexup methotrexate) Injection - FDA

Description : Otrexup contains methotrexate, a folate analog metabolic inhibitor. Chemically, methotrexat...

  • Indications
  • Rheumatoid Arthritis Including Polyarticular Juvenile Idiopathic Arthritis Otrexup is indicated in the management of selected adults with severe, active rheumatoid arthri
  •   Read More
Otrexup (methotrexate) Injection - FDA

Description : Otrexup contains methotrexate, a folate analog metabolic inhibitor. Chemically, metho...

  • Indications
  • Rheumatoid Arthritis Including Polyarticular Juvenile Idiopathic Arthritis Otrexup is indicated in the management of selected adults with severe, active rheumatoid arthr
  •   Read More
Ovcon norethindrone and ethinyl estradiol) Tablets, USP - FDA

Description : OVCON® 50, 28-Day (norethindrone and ethinyl estradiol tablets, USP) provides a continu...

  • Indications
  • Oral contraceptives are indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception. Oral contraceptive products such as OVCO
  •   Read More
Ovcon (norethindrone and ethinyl estradiol) Tablets, USP - FDA

Description : OVCON® 50, 28-Day (norethindrone and ethinyl estradiol tablets, USP) provides a continu...

  • Indications
  • Oral contraceptives are indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception. Oral contraceptive products such as
  •   Read More
Ovide malathion topical (Pronunciation: MAL a THYE on TO - FDA

Description : OVIDE Lotion contains 0.005 g of malathion per mL in a vehicle of isopropyl alcohol (78%), terp...

  • Indications
  • OVIDE Lotion is indicated for patients infected with Pediculus humanus capitis (head lice and their ova) of the scalp hair.
  •   Read More
Ovide malathion topical (Pronunciation: MAL a THYE on TO - Multum

Description : OVIDE Lotion contains 0.005 g of malathion per mL in a vehicle of isopropyl alcohol (78%), terp...

  • Indications
  • OVIDE Lotion is indicated for patients infected with Pediculus humanus capitis (head lice and their ova) of the scalp hair.    
  •   Read More
Ovide malathion topical (Pronunciation: MAL a THYE on TO - FDA

Description : OVIDE Lotion contains 0.005 g of malathion per mL in a vehicle of isopropyl alcohol (78%), ...

  • Indications
  • OVIDE Lotion is indicated for patients infected with Pediculus humanus capitis (head lice and their ova) of the scalp hair.
  •   Read More
Ovide malathion topical (Pronunciation: MAL a THYE on TO - Multum

Description : OVIDE Lotion contains 0.005 g of malathion per mL in a vehicle of isopropyl alcohol (78%), ...

  • Indications
  • OVIDE Lotion is indicated for patients infected with Pediculus humanus capitis (head lice and their ova) of the scalp hair.
  •   Read More
Oxandrin oxandrolone (Pronunciation: ox AN droe lone) - FDA

Description : Oxandrin® (oxandrolone) oral tablets contain 2.5 mg or 10 mg of the anabolic steroid ox...

  • Indications
  • Oxandrin (oxandrolone) is indicated as adjunctive therapy to promote weight gain after weight loss following extensive surgery, chronic infections, or severe trauma, and in so
  •   Read More
Oxandrin oxandrolone (Pronunciation: ox AN droe lone - Multum

Description : Oxandrin® (oxandrolone) oral tablets contain 2.5 mg or 10 mg of the anabolic steroid ox...

  • Indications
  • Oxandrin (oxandrolone) is indicated as adjunctive therapy to promote weight gain after weight loss following extensive surgery, chronic infections, or severe trauma, and in so
  •   Read More
Oxandrin oxandrolone (Pronunciation: ox AN droe lone) - FDA

Description : Oxandrin® (oxandrolone) oral tablets contain 2.5 mg or 10 mg of the anabolic steroid ox...

  • Indications
  • Oxandrin (oxandrolone) is indicated as adjunctive therapy to promote weight gain after weight loss following extensive surgery, chronic infections, or severe trauma, and in so
  •   Read More
Oxandrin oxandrolone (Pronunciation: ox AN droe lone) - Multum

Description : Oxandrin® (oxandrolone) oral tablets contain 2.5 mg or 10 mg of the anabolic steroid ox...

  • Indications
  • Oxandrin (oxandrolone) is indicated as adjunctive therapy to promote weight gain after weight loss following extensive surgery, chronic infections, or severe trauma, and in so
  •   Read More
Oxecta oxycodone HCl, USP) Tablets for Oral Use Only - FDA

Description : OXECTA (oxycodone HCl, USP) tablets are an immediate-release opioid analgesic intended for ...

  • Indications
  • OXECTA is an immediate-release oral formulation of oxycodone HCl indicated for the management of acute and chronic moderate to severe pain where the use of an opioid analgesic
  •   Read More
Oxecta oxycodone HCl, USP) Tablets for Oral Use Only - FDA

Description : OXECTA (oxycodone HCl, USP) tablets are an immediate-release opioid analgesic intended for ...

  • Indications
  • OXECTA is an immediate-release oral formulation of oxycodone HCl indicated for the management of acute and chronic moderate to severe pain where the use of an opioid analgesic
  •   Read More
Oxilan OXILAN┬« (ioxilan (ioxilan (ioxilan) ) ) Injection - FDA

Description : OXILAN® (ioxilan (ioxilan) ) (loxilan (ioxilan (ioxilan) ) Injection) formulations are ...

  • Indications
  • Intraarterial OXILAN® (ioxilan (ioxilan (ioxilan) ) ) Injection (300 mgI/mL) is indicated for cerebral arteriography. OXILAN® (ioxilan (ioxilan (ioxilan) ) ) Inj
  •   Read More
Oxilan ioxilan (ioxilan (ioxilan) ) ) Injection 300 mgl/m - FDA

Description : OXILAN® (ioxilan (ioxilan) ) (loxilan (ioxilan (ioxilan) ) Injection) formulations are ...

  • Indications
  • Intraarterial OXILAN® (ioxilan (ioxilan (ioxilan) ) ) Injection (300 mgI/mL) is indicated for cerebral arteriography. OXILAN® (ioxilan (ioxilan (ioxilan) ) ) Inj
  •   Read More
Oxistat oxiconazole topical (Pronunciation: ox ee CON a zo - FDA

Description : OXISTAT (oxiconazole) Cream and Lotion formulations contain the antifungal active compound ...

  • Indications
  • OXISTAT (oxiconazole) Cream and Lotion are indicated for the topical treatment of the following dermal infections: tinea pedis, tinea cruris, and tinea corporis due to Tri
  •   Read More
Oxistat oxiconazole topical (Pronunciation: ox ee CON a zo - Multum

Description : OXISTAT (oxiconazole) Cream and Lotion formulations contain the antifungal active compound ...

  • Indications
  • OXISTAT (oxiconazole) Cream and Lotion are indicated for the topical treatment of the following dermal infections: tinea pedis, tinea cruris, and tinea corporis due to Tri
  •   Read More
Oxistat oxiconazole topical (Pronunciation: ox ee CON a zo - FDA

Description : OXISTAT (oxiconazole) Cream and Lotion formulations contain the antifungal active compound ...

  • Indications
  • OXISTAT (oxiconazole) Cream and Lotion are indicated for the topical treatment of the following dermal infections: tinea pedis, tinea cruris, and tinea corporis due to Tri
  •   Read More
Oxistat oxiconazole topical (Pronunciation: ox ee CON a zo - Multum

Description : OXISTAT (oxiconazole) Cream and Lotion formulations contain the antifungal active compound ...

  • Indications
  • OXISTAT (oxiconazole) Cream and Lotion are indicated for the topical treatment of the following dermal infections: tinea pedis, tinea cruris, and tinea corporis due to Tri
  •   Read More
Oxtellar XR (oxcarbazepine) Extended-Release Tablets - FDA

Description : Oxtellar XR™ is an antiepileptic drug (AED). Oxtellar XR™ extended-release tabl...

  • Indications
  • Oxtellar XR™ is indicated as adjunctive therapy of partial seizures in adults and in children 6 years to 17 years of age.
  •   Read More
Oxtellar XR (oxcarbazepine) Extended-Release Tablets - FDA

Description : Oxtellar XR™ is an antiepileptic drug (AED). Oxtellar XR™ extended-release tabl...

  • Indications
  • Oxtellar XR™ is indicated as adjunctive therapy of partial seizures in adults and in children 6 years to 17 years of age.
  •   Read More
Oxytrol oxybutynin (transdermal) (Pronunciation: OX i BUE - FDA

Description : OXYTROL (oxybutynin) Transdermal System is designed to deliver oxybutynin over a 3- to 4day...

  • Indications
  • OXYTROL is a muscarinic antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency.
  •   Read More
Oxytrol oxybutynin (transdermal) (Pronunciation: OX i BUE - Multum

Description : OXYTROL (oxybutynin) Transdermal System is designed to deliver oxybutynin over a 3- to 4day...

  • Indications
  • OXYTROL is a muscarinic antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency.
  •   Read More
Oxytrol oxybutynin (transdermal) (Pronunciation: OX i BUE - FDA

Description : OXYTROL (oxybutynin) Transdermal System is designed to deliver oxybutynin over a 3- to 4day...

  • Indications
  • OXYTROL is a muscarinic antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency.  
  •   Read More
Oxytrol oxybutynin (transdermal) (Pronunciation: OX i BUE - Multum

Description : OXYTROL (oxybutynin) Transdermal System is designed to deliver oxybutynin over a 3- to 4day...

  • Indications
  • OXYTROL is a muscarinic antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency.
  •   Read More
Ozurdex  dexamethasone intravitreal implant (Pronunciation - FDA

Description : OZURDEX® is an intravitreal implant containing 0.7 mg (700 mcg) dexamethasone in the NO...

  • Indications
  • Retinal Vein Occlusion OZURDEX® (dexamethasone) intravitreal implant is indicated for the treatment of macular edema following branch retinal vein occlusion (BRVO) or
  •   Read More
Ozurdex  dexamethasone intravitreal implant (Pronunciation - Multum

Description : OZURDEX® is an intravitreal implant containing 0.7 mg (700 mcg) dexamethasone in the NO...

  • Indications
  • Retinal Vein Occlusion OZURDEX® (dexamethasone) intravitreal implant is indicated for the treatment of macular edema following branch retinal vein occlusion (BRVO) or
  •   Read More
Ozurdex dexamethasone intravitreal implant (Pronunciation: - FDA

Description : OZURDEX® is an intravitreal implant containing 0.7 mg (700 mcg) dexamethasone in the NO...

  • Indications
  • Retinal Vein Occlusion OZURDEX® (dexamethasone) intravitreal implant is indicated for the treatment of macular edema following branch retinal vein occlusion (BRVO) or
  •   Read More
Ozurdex  dexamethasone intravitreal implant (Pronunciation - Multum

Description : OZURDEX® is an intravitreal implant containing 0.7 mg (700 mcg) dexamethasone in the NO...

  • Indications
  • Retinal Vein Occlusion OZURDEX® (dexamethasone) intravitreal implant is indicated for the treatment of macular edema following branch retinal vein occlusion (BRVO) or
  •   Read More
Rx Scoops
Featured Topics
Advertisements
Copyrights ©2014: Rx Scoops - Designed & Developed By - GOIGI